Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer

NCT00303992 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: irinotecan hydrochloride

Sponsor

University of California, San Francisco

Collaborators

[object Object]